The current NB11 market cap is 99.59M. The company's latest EPS is USD -0.5424 and P/E is -1.29.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 9.86M | 4.9M | 892k | 107k | 7.38M |
Operating Income | -15.79M | -30.17M | -72.75M | -114.59M | -83.35M |
Net Income | -18.65M | -32.22M | -70.47M | -107.76M | -82.47M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 37.03M | 152.58M | 221.17M | 153.85M | 91.83M |
Total Liabilities | 24.08M | 29.18M | 33.64M | 43.25M | 34.03M |
Total Equity | 12.95M | 123.4M | 187.53M | 110.6M | 57.81M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -13.09M | -23.75M | -59.83M | -94.78M | -70.45M |
Investing | -850k | -1.22M | -49.1M | -20.42M | 43.95M |
Financing | 15.96M | 138.31M | 125.8M | 17.46M | 15.24M |
Market Cap | 99.59M |
Price to Earnings Ratio | -1.29 |
Price to Sales Ratio | 14.43 |
Price to Cash Ratio | 3.06 |
Price to Book Ratio | 1.84 |
Dividend Yield | - |
Shares Outstanding | 152.04M |
Average Volume (1 week) | 8.82k |
Average Volume (1 Month) | 4.97k |
52 Week Change | -14.04% |
52 Week High | 1.45 |
52 Week Low | 0.5044 |
Spread (Intraday) | 0.02 (2.35%) |
Company Name | Vaxart Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://vaxart.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.